A Phase 1 Study Evaluating Safety and Efficacy of Parsaclisib in Combination with Bendamustine + Obinutuzumab in Patients with Relapsed or Refractory Follicular Lymphoma (R/R FL) (CITADEL-102)
HEMATOLOGICAL ONCOLOGY（2023）
关键词
bendamustine hydrochloride,follicular,lymphoma,obinutuzumab,parsaclisib,phosphatidylinositol 3-kinase
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要